Diffusion Tensor Images in Children with Early-Treated, Chronic, Malignant Phenylketonuric: Correlation with Intelligence Assessment

References

1. ↵
   Mallolas J, Vilaseca MA, Campisto J, et al. Clinical, biochemical, neurological and molecular study of 11 patients with new mutations in PAH gene. Rev Neurol 2000;31:907–910

   PubMed
2. Scriver CR. Science, medicine and phenylketonuria. Acta Paediatr 1995;407(Suppl):11–18
3. Lou HC, Guttler F, Lykkelung C, et al. Decreased vigilance and neurotransmitter synthesis after discontinuation of dietary treatment for phenylketonuria in adolescents. Eur J Pediatr 1985;144:17–20

   CrossRefPubMedWeb of Science
4. ↵
   Pratt OE. Transport inhibition in the pathology of phenylketonuria and other inherited metabolic diseases. J Inherit Metab Dis 1979;2(Suppl 5):75–81
5. ↵
   Pietz J. Neurological aspects of adult phenylketonuria. Curr Opin Neurol 1998;11:679–688

   CrossRefPubMed
6. ↵
   Malamud N. Neuropathology of phenylketonuria. J Neuropathol Exp Neurol 1966;25:254–268

   PubMedWeb of Science
7. ↵
   Poser CM, Van Bogaert L. Neuropathologic observations in phenylketonuria. Brain 1959;82:1–9

   Abstract/FREE Full Text
8. ↵
   Smith I, Beaseley MG, Ades AE. Effect on intelligence of relaxing the low phenylalanine diet in phenylketonuria. Arch Dis Child 1991;65:311–316
9. ↵
   Feldmann R, Denecke J, Pietsch M, et al. Phenylketonuria: no specific frontal lobe-dependent neuropsychological deficits of early-treated patients in comparison with diabetics. Pediatr Res 2002;51:761–765

   PubMed
10. ↵
    Phillips MD, McGraw P, Lowe MJ, et al. Diffusion-weighted imaging of white matter abnormalities in patients with phenylketonuria. AJNR Am J Neuroradiol 2001;22:1583–1586

    Abstract/FREE Full Text
11. ↵
    Schmidt H, Ullrich K, Korinthernberg R, Peters PE. Basal ganglion calcification in hyperphenylalaninemia due to deficiency of dihydropteridine reductase. Pediatr Radiol 1998;19:54–56
12. Sugita R, Takahashi S, Ishii K, et al. Brain CT and MR findings in hyperphenylaalaninemia due to dihydropteridine reductase deficiency (variant of phenylketonuria). J Comput Assist Tomogr 1990;5:699–703
13. ↵
    Brismar J, Aqeel A, Gascon G, Ozand P. Malignant hyperphenylalaninemia: CT and MR of the brain. AJNR Am J Neuroradiol 1990;11:135–138

    Abstract/FREE Full Text
14. Gudinchet F, Maeder PH, Meuli RA, Deonna TH, Mathieu JM. Cranial CT and MRI in malignant phenylketonuria. Pediatr Radiol 1992;22:223–224

    PubMed
15. ↵
    Pietz J, Meyding-Lamade UK, Schmidt H. Magnetic resonance imaging of the brain in adolescents with phenylketonuria and in one case of 6-pyruvoyl tetrahydropteridine synthase deficiency. Eur J Pediatr 1996;155:S69–S73
16. Cleary MA, Walter JH, Wraith JE, et al. Magnetic resonance imaging in phenylketonuria: reversal of cerebral white matter change. J Pediatr 1995;127:251–255

    CrossRefPubMedWeb of Science
17. ↵
    Thompson AJ, Smith I, Brenton D, et al. Neurological deterioration in young adults with phenylketonuria. Lancet 1990;336:602–605

    CrossRefPubMedWeb of Science
18. ↵
    Cleary MA, Walter JH, Wraith JE, et al. Magnetic resonance imaging of the brain in phenylketonuria. Lancet 1994;344:87–90

    CrossRefPubMedWeb of Science
19. Pearsen KD, Gean-Marton AD, Levy HL, et al. Phenylketonuria: MR imaging of the brain with clinical correlation. Radiology 1990;177:437–440

    PubMedWeb of Science
20. ↵
    Bick U, Fahrendorf G, Ludolph AC, et al. Disturbed myelination in patients with treated hyperphenylalaninaemia: evaluation with magnetic resonance imaging. Eur J Pediatr 1991;150:185–189

    CrossRefPubMedWeb of Science
21. ↵
    Pietz J, Kreis R, Schmidt H, et al. Phenylketonuria: findings at MR imaging and localized in vivo H-1 MR spectroscopy of the brain in patients with early treatment. Radiology 1996;201:413–420

    PubMedWeb of Science
22. ↵
    Dezortova M, Hajek M, Tintera J, et al. MR in phenylketonuria-related brain lesions. Acta Radiol 2001;42:459–466

    PubMed
23. ↵
    Huppi PS, Maier SE, Peled S, et al. Microstructural development of human newborn cerebral white matter assessed in vivo by diffusion tensor magnetic resonance imaging. Pediatr Res 1998;44:584–590

    CrossRefPubMedWeb of Science
24. ↵
    Neil JJ, Shiran SI, McKinstry RC, et al. Normal brain in human newborns: apparent diffusion coefficient and diffusion anisotropy measured by using diffusion tensor MR imaging. Radiology 1998;209:57–66

    PubMedWeb of Science
25. ↵
    Eichler FS, Itoh R, Barker PB, et al. Proton MR spectroscopic and diffusion tensor brain MR imaging in X-linked adrenoleukodystrophy: initial experience. Radiology 2002;225:245–252

    PubMedWeb of Science
26. ↵
    Chan JM. Chinese Version of the Wechsler Intelligence Scale for Children-Revised [Chinese]. Taipei, Taiwan: Chinese Behavior Science Cooperation;1979
27. ↵
    Tseng WYI, Reese TG, Weisskoff RM, Wedeen VJ. Cardiac diffusion tensor MRI in vivo without strain correction. Magn Reson Med 1999;42:393–403

    CrossRefPubMedWeb of Science
28. ↵
    Longhi R, Rottoli A, Vittorelli A, et al. Trace elements nutriture in hyperphenylalaninemic patients. Long-term follow up study. Eur J Pediatr 1987;146:32–37
29. ↵
    Lou HC, Toft PB, Andersen J, et al. An occipito-temporal syndrome in adolescents with optimally controlled hyperphenylalaninaemia. J Inher Metab Dis 1992;15:687–695

    CrossRefPubMedWeb of Science
30. ↵
    Chien YS, Peng SSF, Wang TR, Hwu WL. Cranial magnetic resonance spectroscopy of tetrahydrobiopterin deficiency. AJNR Am J Neuroradiol 2002;23:1055–1058

    Abstract/FREE Full Text
31. ↵
    Huttenlocher PR. The neuropathology of phenylketonuria: human and animal studies. Eur J Pediatr 2000;159:S102–S106